Mechanism of mannose toxicity.

PubWeight™: 1.09‹?› | Rank: Top 10%

🔗 View Article (PMID 3096320)

Published in Biochem Biophys Res Commun on October 15, 1986

Authors

M de la Fuente, P F Peñas, A Sols

Articles by these authors

(truncated to the top 100)

Glycerol metabolism in yeasts. Pathways of utilization and production. Eur J Biochem (1968) 2.04

Studies on the mechanism of the antifungal action of benzoate. Biochem J (1983) 1.97

Specificity of the constitutive hexose transport in yeast. Eur J Biochem (1968) 1.90

Metabolite repression of fructose 1,6-diphosphatase in yeast. Biochem Biophys Res Commun (1967) 1.82

Outcome from severe head injury related to the type of intracranial lesion. A computerized tomography study. J Neurosurg (1983) 1.66

Regulation of Escherichia coli phosphofructokinase in situ. Biochem Biophys Res Commun (1973) 1.63

Two interconvertible forms of yeast phosphofructokinase with different sensitivity to endproduct inhibition. Biochem Biophys Res Commun (1964) 1.60

Transport and phosphorylation of sugars in adipose tissue. Biochem J (1963) 1.44

Platelet-released growth factors enhance the secretion of hyaluronic acid and induce hepatocyte growth factor production by synovial fibroblasts from arthritic patients. Rheumatology (Oxford) (2007) 1.41

Recall phenomenon with the unusual presence of eccrine squamous syringometaplasia. Br J Dermatol (1995) 1.39

Induced fit in yeast hexokinase. Eur J Biochem (1970) 1.28

Apparent unbalance between the activities of 6-phosphogluconate and glucose-6-phosphate dehydrogenases in rat liver. Biochem Biophys Res Commun (1973) 1.24

Quality of life in mild to moderate acne: relationship to clinical severity and factors influencing change with treatment. J Eur Acad Dermatol Venereol (2007) 1.24

Regulation of liver pyruvate kinase and the phosphoenolpyruvate crossroads. Eur J Biochem (1970) 1.21

Fibroblastic response to treatment with different preparations rich in growth factors. Cell Prolif (2009) 1.21

Enzymes involved in fructose metabolism in lir and the glyceraldehyde metabolic crossroads. Eur J Biochem (1969) 1.15

Pyruvate kinase. Classes of regulatory isoenzymes in mammalian tissues. Eur J Biochem (1973) 1.14

Modulation of muscle phosphofructokinase at physiological concentration of enzyme. J Biol Chem (1985) 1.13

Effect of polyethylene glycol on the kinetic behaviour of pyruvate kinase and other potentially regulatory liver enzymes. FEBS Lett (1985) 1.12

Lens major intrinsic protein (MIP) promotes adhesion when reconstituted into large unilamellar liposomes. Biochemistry (1994) 1.10

Regulation of the level of key enzymes of glycolysis and gluconeogenesis in liver. Eur J Biochem (1969) 1.08

Induced biosynthesis of liver glucokinase. Adv Enzyme Regul (1964) 1.06

Regulation of enzyme activity in the cell: effect of enzyme concentration. FASEB J (1991) 1.04

The kinetics of yeast hexokinase in the light of the induced fit involved in the binding of its sugar substrate. Eur J Biochem (1970) 1.03

Distribution of hexokinase and glucokinase between parenchymal and non-parenchymal cells of rat liver. FEBS Lett (1969) 1.00

Post-kala-azar dermal Leishmaniasis in an HIV-patient. Int J Dermatol (1996) 0.99

Gluconeogenesis from serine by the serine-dehydratase-dependent pathway in rat liver. Eur J Biochem (1974) 0.98

The Spanish version of Skindex-29. Int J Dermatol (2000) 0.95

Oxaloacetate metabolic crossroads in liver. Enzyme compartmentation and regulation of gluconeogenesis. Mol Cell Biochem (1974) 0.93

Multimodulation of enzyme activity. Curr Top Cell Regul (1981) 0.93

Harmaline: a competitive inhibitor of Na ion in the (Na+ + K+)-ATPase system. J Membr Biol (1973) 0.92

Specific activation by fructose 2,6-bisphosphate and inhibition by P-enolpyruvate of ascites tumor phosphofructokinase. Biochem Biophys Res Commun (1982) 0.90

Location of the enzymes of the oxalacetate metabolic cross-roads in rat liver mitochondria. Biochem Biophys Res Commun (1969) 0.90

Bombesin, gastrin-releasing peptide, and neuromedin C modulate murine lymphocyte proliferation through adherent accessory cells and activate protein kinase C. Peptides (1994) 0.89

Permeabilization of animal cells for kinetic studies of intracellular enzymes: in situ behavior of the glycolytic enzymes of erythrocytes. Proc Natl Acad Sci U S A (1980) 0.88

Characterization of aconitate hydratase from mitochondria and cytoplasm of ascites tumor cells. Biochem Cell Biol (1988) 0.88

Rat liver 6-phosphogluconolactonase: a low Km enzyme. Biochem Biophys Res Commun (1976) 0.88

Calcium channel and membrane fusion activity of synexin and other members of the Annexin gene family. Biophys J (1992) 0.88

Association of Helicobacter pylori infection with psoriasis and lichen planus: prevalence and effect of eradication therapy. Arch Dermatol (2000) 0.87

Salmonella enterica infections in Spanish swine fattening units. Zoonoses Public Health (2007) 0.87

Simplified detection of myocardial ischemia by seismocardiography. Differentiation between causes of altered myocardial function. Herz (2013) 0.87

Leishmaniasis presenting as a dermatomyositis-like eruption in AIDS. J Am Acad Dermatol (1996) 0.86

Malignant melanoma appearing in a seborrhoeic keratosis. Br J Dermatol (1995) 0.86

Efficacy, safety and predictive factors of therapeutic success with sildenafil for erectile dysfunction in patients with different spinal cord injuries. Spinal Cord (2001) 0.86

The nicotinic acetylcholine receptor of the bovine chromaffin cell, a new target for dihydropyridines. Eur J Pharmacol (1993) 0.86

Insulin-dependent synthesis of glucokinase. J Cell Physiol (1965) 0.86

Palmar-plantar erythrodysaesthesia syndrome and other cutaneous side-effects after treatment with Tegafur. Acta Derm Venereol (1997) 0.86

Subependymoma of the lateral ventricle. Surg Neurol (1981) 0.82

Posterior uveitis in Hodgkin's disease. Aust N Z J Ophthalmol (1999) 0.82

Human synexin (annexin VII) polymorphisms: tissue specificity and expression in Escherichia coli. Biochem Soc Trans (1990) 0.81

Increased cerebrospinal fluid cAMP levels in Alzheimer's disease. Brain Res (1999) 0.81

Requirement of macrophage metabolic activity for T-lymphocyte activation. Rev Esp Fisiol (1982) 0.81

Pustular acral erythema in a patient with acute graft-versus-host disease. J Eur Acad Dermatol Venereol (2003) 0.81

Specificity of hexokinases towards some uncommon substrates and inhibitors. FEBS Lett (1980) 0.80

Allosteric inhibition of brain hexokinase by glucose 6-phosphate in the reverse reaction. Arch Biochem Biophys (1985) 0.80

Allosteric glutaminase in rat liver of likely regulatory significance. FEBS Lett (1968) 0.80

[Evaluation of a 2D fluoroscopy-based navigation system for insertion of the dynamic hip screw (DHS): an experimental study]. Rofo (2011) 0.80

Brain hexokinase has two spatially discrete sites for binding of glucose-6-phosphate. J Biol Chem (1980) 0.79

Targeting the anionic region of human protease-activated receptor 4 inhibits platelet aggregation and thrombosis without interfering with hemostasis. J Thromb Haemost (2014) 0.79

Biphasic effect of fructose 2,6-bisphosphate on the liver fructose-1,6-bisphosphatase: mechanistic and physiological implications. FEBS Lett (1984) 0.79

Regulation of the concentration or activity of pyruvate kinase in yeasts and its relationship to gluconeogenesis. Biochem J (1967) 0.79

[Evaluation of a 2D fluoroscopy-based navigation system for insertion of femoral neck screws. An experimental study]. Unfallchirurg (2012) 0.79

Characterization of sex chromosomes in rainbow trout and coho salmon using fluorescence in situ hybridization (FISH). Genetica (2001) 0.79

Pseudoxanthoma elasticum-like papillary dermal elastolysis. A report of two cases and review of the literature. Acta Derm Venereol (1997) 0.79

Reversible inactivation by elemental sulfur and mercurials of rat liver serine dehydratase and certain sulfhydryl enzymes. Biochem Biophys Res Commun (1970) 0.78

Glyceraldehyde-3-phosphate dehydrogenase activity studied under physiological conditions with a linear assay. Biochem Biophys Res Commun (1978) 0.78

Reticular erythematous mucinosis associated with human immunodeficiency virus infection. Dermatology (1995) 0.78

Improvement of the macrophage functions in prematurely ageing mice by a diet supplemented with thiolic antioxidants. Cell Mol Biol (Noisy-le-grand) (2004) 0.77

Pituitary adenylate cyclase-activating polypeptide (PACAP-38) stimulates rat peritoneal macrophage functions. Peptides (1996) 0.77

A barium-dependent chromaffin granule aggregating protein from bovine adrenal medulla and other tissues. Ann N Y Acad Sci (1991) 0.77

A severe case of pachyonychia congenita type I due to a novel proline mutation in keratin 6a. Br J Dermatol (2005) 0.77

Simulation of the first hydration shell of nucleosides D4T and thymidine: structures obtained using MP2 and DFT methods. J Phys Chem B (2009) 0.77

Fructokinase assay with a specific spectrophotometric method using 1-phosphofructokinase. Enzymol Biol Clin (Basel) (1967) 0.77

Effect of age, culture medium and lymphocyte presence on ascorbate content of peritoneal macrophages from mice and guinea pigs during phagocytosis. Int Arch Allergy Appl Immunol (1990) 0.77

LightCycler PCR assay for genotyping codon 634 mutations in the RET protooncogene. Clin Chem (2001) 0.77

Inhibition by homocysteine of serine dehydratase and other pyridoxal 5'-phosphate enzymes of the rat through cofactor blockage. Arch Biochem Biophys (1971) 0.77

Cutaneous lichenoid graft-versus-host disease mimicking lupus erythematosus. Lupus (2008) 0.77

Maculopapular eruption with enlarged macrophages in eight patients receiving G-CSF or GM-CSF. J Eur Acad Dermatol Venereol (2004) 0.77

Fusion of coronary angiography and stress echocardiography for myocardial viability evaluation. Int J Comput Assist Radiol Surg (2014) 0.76

Intraventricular hemorrhage in severe head injury. J Neurosurg (1983) 0.76

Anabolic steroids and lymphocyte function in sedentary and exercise-trained rats. J Steroid Biochem Mol Biol (1996) 0.76

Fructose 2,6-bisphosphate and enzymatic activities for its metabolism in ascites tumor. Curr Top Cell Regul (1985) 0.76

Myocardial effects of local shock wave therapy in a Langendorff model. Ultrasonics (2013) 0.76

Pyruvate dehydrogenase complex of ascites tumour. Activation by AMP and other properties of potential significance in metabolic regulation. Biochem J (1980) 0.76

Development and characterization of a three-dimensional co-culture model of tumor T cell infiltration. Biofabrication (2016) 0.76

Implication of MT1-MMP in the maturation steps of benign melanocytic nevi. J Cutan Pathol (2006) 0.75

Actinomycotic brain abscess: CT findings. J Comput Assist Tomogr (1985) 0.75

Cutaneous heterotopic meningeal nodules. Arch Dermatol (1995) 0.75

Pachyonychia congenita and hidradenitis suppurativa: no response to infliximab therapy. J Eur Acad Dermatol Venereol (2008) 0.75

Regulation of glycolysis and gluconeogenesis at the enzyme level. Biochem J (1969) 0.75

Stimulation of phagocytic processes and antibody-dependent cellular cytotoxicity of human neutrophils by cefmetazole. Microbiol Immunol (1991) 0.75

Non-ischaemic causes of transient ischaemic attacks and minor strokes. J Neurol Neurosurg Psychiatry (1994) 0.75

Association between zalcitabine therapy for human immunodeficiency virus and granuloma annulare? Arch Dermatol (2001) 0.75

Interconversion phenomena between two kinetic forms of class a pyruvate kinase from Ehrlich ascites tumor cells. Mol Cell Biochem (1976) 0.75

Properties and modification of recombinant human synexin (annexin VII). Ann N Y Acad Sci (1991) 0.75

[Femoral head dysplasia and its relationship to femoral head necrosis (Perthes' disease)]. Z Orthop Ihre Grenzgeb (1994) 0.75

[Experience of the National Autonomous Board for Certification of Medical Specialties]. Rev Med Chil (1991) 0.75

Delayed appearance of anti-myelin-associated glycoprotein antibodies in a patient with chronic demyelinating polyneuropathy. Ann Neurol (1993) 0.75

[Magnitude and declared causes of absenteeism for health reasons among faculty and students of a medical school]. Rev Med Chil (1994) 0.75

Effects of imipenem and cefmetazol on lymphocyte receptors CD2, Fc and C3b of complement. Comp Immunol Microbiol Infect Dis (1991) 0.75